Abstract
Single Best Answer
You see a 67-year-old patient with known type II diabetes mellitus and cardiovascular disease. He is currently on metformin, but his glycaemic control is still not to target.
Sodium-glucose cotransporte-2 inhibitors (SGLT-2 inhibitors) or glucagon-like peptide-1 receptor agonist (GLP-1 agonist) Sodium-glucose cotransporte-2 inhibitors (SGLT-2 inhibitors) or insulin Sulfonylurea or glucagon-like peptide-1 receptor agonist (GLP-1 agonist) Sulfonylurea or insulin Sulfonylurea or sodium-glucose cotransporte-2 inhibitors (SGLT-2 inhibitors)
Answer DOI: 10.1177/17557380221088779q